Is there any assurance of provision of antiretrviral drugs after DART?
The governments of both Uganda and Zimbabwe pledged to provide access to antiretroviral (ARV) drugs for DART participants after the trial finished. Around 2,000 participants were based in Uganda, the majority at clinics that had other free treatment programmes available. Around 800 participants were based in Zimbabwe where the existing DART clinic has been developed into a national HIV treatment centre. See the Responsible DART Trial closure page for further information.